Literature DB >> 26204990

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).

Karen A Hicks, James E Tcheng, Biykem Bozkurt, Bernard R Chaitman, Donald E Cutlip, Andrew Farb, Gregg C Fonarow, Jeffrey P Jacobs, Michael R Jaff, Judith H Lichtman, Marian C Limacher, Kenneth W Mahaffey, Roxana Mehran, Steven E Nissen, Eric E Smith, Shari L Targum.   

Abstract

Mesh：

Year:  2015        PMID： 26204990     DOI： 10.1007/s12350-015-0209-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  52 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

2.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

3.  [A new classification of coronary bifurcation lesions].

Authors:  Alfonso Medina; José Suárez de Lezo; Manuel Pan
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

4.  ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.

Authors:  Robert C Hendel; Biykem Bozkurt; Gregg C Fonarow; Jeffrey P Jacobs; Judith H Lichtman; Eric E Smith; James E Tcheng; Tracy Y Wang; William S Weintraub
Journal:  Circulation       Date:  2013-11-15       Impact factor: 29.690

5.  Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.

Authors:  Mark H Drazner; Anne S Hellkamp; Carl V Leier; Monica R Shah; Leslie W Miller; Stuart D Russell; James B Young; Robert M Califf; Anju Nohria
Journal:  Circ Heart Fail       Date:  2008-09       Impact factor: 8.790

6.  Letter: Grading of angina pectoris.

Authors:  L Campeau
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

7.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

8.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

9.  caCORE version 3: Implementation of a model driven, service-oriented architecture for semantic interoperability.

Authors:  George A Komatsoulis; Denise B Warzel; Francis W Hartel; Krishnakant Shanbhag; Ram Chilukuri; Gilberto Fragoso; Sherri de Coronado; Dianne M Reeves; Jillaine B Hadfield; Christophe Ludet; Peter A Covitz
Journal:  J Biomed Inform       Date:  2007-04-02       Impact factor: 6.317

10.  Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Authors:  Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534
View more
  15 in total

1.  Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators.

Authors:  Hao Huang; Yu Deng; Sijing Cheng; Nixiao Zhang; Minsi Cai; Hongxia Niu; Xuhua Chen; Min Gu; Xi Liu; Yu Yu; Wei Hua
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

2.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

3.  Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block.

Authors:  Alberto Aimo; Alessandro Valleggi; Andrea Barison; Sara Salerni; Michele Emdin; Giovanni Donato Aquaro
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-26       Impact factor: 2.357

4.  Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study.

Authors:  Hon-Yen Wu; Chiao-Ling Peng; Pei-Chun Chen; Chih-Kang Chiang; Chee-Jen Chang; Jenq-Wen Huang; Yu-Sen Peng; Yu-Kang Tu; Tzong-Shinn Chu; Kuan-Yu Hung; Kuo-Liong Chien
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

5.  CArbon dioxide surgical field flooding and aortic NO-touch off-pump coronary artery bypass grafting to reduce Neurological injuries after surgical coronary revascularisation (CANON): protocol for a randomised, controlled, investigator and patient blinded single-centre superiority trial with three parallel arms.

Authors:  Szwed Krzysztof; Pawliszak Wojciech; Serafin Zbigniew; Kowalewski Mariusz; Tomczyk Remigiusz; Perlinski Damian; Szwed Magdalena; Tomaszewska Marta; Anisimowicz Lech; Borkowska Alina
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

Review 6.  The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zhaofeng Shi; Chen Zhao; Jiayuan Hu; Qianqian Dai; Manke Guan; Changming Zhong; Guihua Tian; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-18       Impact factor: 2.629

7.  Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study.

Authors:  T M Hommels; R S Hermanides; S Rasoul; B Berta; A J J IJsselmuiden; G A J Jessurun; E Benit; B Pereira; G De Luca; E Kedhi
Journal:  Cardiovasc Diabetol       Date:  2019-03-09       Impact factor: 9.951

8.  Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Marilyn K Glassberg; Steven D Nathan; Chin-Yu Lin; Elizabeth A Morgenthien; John L Stauffer; Willis Chou; Paul W Noble
Journal:  Adv Ther       Date:  2019-08-10       Impact factor: 3.845

9.  Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.

Authors:  Min Tian; Rui Li; Zhilei Shan; Dao Wen Wang; Jiangang Jiang; Guanglin Cui
Journal:  Lipids Health Dis       Date:  2019-11-19       Impact factor: 3.876

10.  Coronary Thermodilution Waveforms After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognosis.

Authors:  Shu Ning Yew; David Carrick; David Corcoran; Nadeem Ahmed; Jaclyn Carberry; Vannesa Teng Yue May; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Stuart Hood; Stuart Watkins; Andrew Davie; Ahmed Mahrous; Ify Mordi; Ian Ford; Keith G Oldroyd; Colin Berry
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.